recent study, as well as an earlier study that showed the proof of concept. Molecular diagnostic firm OncoCyte plans to launch its blood - based test to detect cancer later this year after a successful study of 300 lung cancer patients . The company ’s algorithm was able to correctly identify tumor nodules , which can help physicians determine malignancies and cancer . The technology could keep doctors from performing potentially risky and expensive tumour tests , and in future could help to eliminate invasive tests for cancer altogether . OncoCyte plans to apply for certification and carry out clinical validation studies before commercialising its technology .
Molecular diagnostic firm OncoCyte plans to launch its blood - based test to detect cancer later this year after a successful study of 300 lung cancer patients . The company ’s algorithm was able to correctly identify tumor nodules , which can help physicians determine malignancies and cancer . The technology could keep doctors from performing potentially risky and expensive tumour tests , and in future could help to eliminate invasive tests for cancer altogether . OncoCyte plans to apply for certification and carry out clinical validation studies before commercialising its technology .